Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vericiguat Drug Use Two-arm Investigation in Chronic Heart Failure

NCT05666518 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT05666518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05666518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vericiguat Drug Use Two-arm Investigation in Chronic Heart Failure
Lead sponsor
Bayer
Phase
Observational
Overall status
Recruiting
Start date
August 31, 2022
Completion date
December 31, 2028
Enrollment
1,400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure